Morning, Thursday, 20th February 2020
THIS EVENT IS CPD CERTIFIED
This seminar will consider global coordination to tackle antimicrobial resistance (AMR) and the next steps for meeting the goals of the UK strategy.
It is timed to bring together stakeholders and policymakers to discuss the way forward for global collaboration to tackle AMR, in light of the recent report from the UN Interagency Coordination Group on Antimicrobial Resistance’s No Time to Wait: Securing the future from drug-resistant infections which called for systematic and meaningful engagement across sectors at the global, national and local level.
The seminar takes place following the announcement of the trial of a new payment model for antibiotics by NICE and NHS England and NHS Improvement, which would pay pharmaceutical companies upfront for the value of their medicines rather than by volume of antibiotic used.
Delegates will consider what will be needed from a new payment model to encourage the development of new antimicrobials and whilst ensuring that companies get the return on the investment required to develop new drugs, without incentivising the overuse of antibiotics.
We expect further discussion on the next steps for meeting the goals of the UK Government’s 5-year action plan and 20-year vision for AMR.
Attendees will assess the impact of the plan and the way forward for delivering key ambitions - including improving infection prevention and control, strengthening surveillance capacity and collaborating across the human, animal and environmental health sectors.
Further sessions will consider the Government’s review into overprescribing and how to encourage the appropriate use of antibiotics, looking at increasing patient awareness of AMR, improving diagnostic testing of infections and engaging with clinicians, vets and farmers to reduce antibiotic use.